The Guidelines for Pharmacy team has produced the following directory of COVID-19 information and guidance for community pharmacy. This page will be updated as and when relevant guidance/information is made available.
Jump to:
COVID-19 vaccination
The latest guidance on the COVID-19 vaccines and vaccination programmes.
UKHSA
- COVID-19 vaccination: blood clotting information for healthcare professionals
- Clinical investigation and management of COVID-19 vaccine induced thrombosis and thrombocytopenia
PHE
Specialist Pharmacy Service
Key COVID-19 guidance for community pharmacy
- The International Pharmaceutical Federation: guidance on COVID-19 for pharmacists and the pharmacy workforce
- Specialist Pharmacy Service: guidance on drug monitoring during COVID-19
NHS England and NHS Improvement
- Coronavirus guidance for primary care
- Regular updates and guidance for community pharmacy regarding COVID-19
- SOP for community pharmacists
- Home delivery of prescription medicines during the COVID-19 outbreak
- Preparing for community pharmacy to contribute to the COVID-19 vaccination programme
- Enhanced Service Specification: COVID-19 vaccination programme 2020/21
- Shielding and protecting people who are clinically extremely vulnerable from COVID-19
- Therapeutic alert through the Central Alerting System on the use of inhaled budesonide for adults with COVID-19
NICE
- COVID-19 rapid evidence summary: acute use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19
- Managing the long-term effects of COVID-19, often described as ‘long COVID’
- A series of rapid guidelines on the active management of COVID-19 infection
- Clinical knowledge summary (CKS) on coronavirus
UKHSA
- Advice on the investigation and management of patients who may be infected with a new SARS-CoV-2 Variant of Concern
- Guidance on the management of staff, patients and residents who have been exposed to COVID-19
- Guidance for people advised to self isolate
- Guidance on the national lockdown
- Infection prevention and control for COVID-19
- SOP on how to run a safe and effective medicines reuse scheme in a care home or hospice
- Yellow Card reporting site for healthcare professionals, patients, and caregivers to report:
- suspected side effects associated with any medicine used in patients with confirmed or suspected COVID-19
- incidents involving medical devices used in relation to COVID-19
- Updates to UKHSA/PHE guidance for COVID-19 are found on the MHRA central alerting system (CAS)
- COVID-19: long-term health effects
- COVID-19: supporting adults with learning disabilities and autistic adults
- COVID-19: summary guidance for service providers on point of care or near-person tests for diagnosis and management
- COVID-19 surveillance and immunity studies
PHE
General Pharmaceutical Council
- Joint statement signed by the General Pharmaceutical Council, the Royal Pharmaceutical Society, the Association of Pharmacy Technicians UK, the Pharmaceutical Society of Northern Ireland, and Pharmacy Forum NI, on emphasising social distancing during the COVID-19 pandemic
Pharmaceutical Services Negotiating Committee
- Pharmaceutical Services Negotiating Committee (PSNC): overview of the Pandemic Delivery Service
- Digital guide to the Pandemic Delivery Service for community pharmacy contractors
- Joint guidance: dealing with unwanted medicines that have been returned to community pharmacies in England by PSNC, the National Pharmacy Association, the Royal Pharmaceutical Society and the Community Pharmacy Patient Safety Group
Royal Pharmaceutical Society
SIGN
- Guidance on assessment of COVID-19 in primary care
Information for specific groups
The following is a list of links providing additional information for specific groups. This will be updated regularly as new information is published.
Allergy
- The British Society for Allergy and Clinical Immunology has published modifications for allergy services during COVID-19 pandemic:
Cardiovascular
ACEi and ARBs
- Primary Care Cardiovascular Society: advice about COVID-19 for patients taking angiotensin converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARBs)
- The British Cardiovascular Society and British Society for Heart Failure: joint statement on treatment with ACEi or ARB in relation to COVID-19
Care of the elderly
- The British Geriatrics Society: list of current official UK/global advice and publications relating to older people’s healthcare during COVID-19
Diabetes
- Guidance on practical recommendations for the management of diabetes in patients with COVID-19
- Diabetes UK: COVID-19 guidance for people living with diabetes and their families
- Primary Care Diabetes Society: COVID-19 and diabetes fact sheet
Musculoskeletal and joints
- The Royal Osteoporosis Society: COVID-19 resource hub
Respiratory
- Asthma UK: health advice concerning COVID-19 for people with asthma
- British Thoracic Society: information to support the respiratory community during the COVID-19 outbreak
- Global Initiative for Asthma: answers to frequently asked questions on the management of asthma during the COVID-19 outbreak
- Global Initiative for Chronic Obstructive Lung Disease: brief list of guidance for patients with COPD
Sexual health
Skin and wound care
- International Psoriasis Council: statement on the COVID-19 outbreak
- British Association of Dermatologists: statement on dry skin and frequent handwashing to reduce COVID-19 risk
Women’s health
- Faculty of Sexual and Reproductive Healthcare (FSRH) guidance:
- guide for patients to help them stay informed about contraception and abortion services
- clinical advice to support provision of effective contraception during the COVID-19 outbreak
- Primary Care Women’s Health Forum: PCS COVID-19 Community Contraception Guide
No comments yet